Zhende Medical(SH:603301) Zheng Quan Zhi Xing·2025-07-23 16:23General Principles - The company establishes a management system for the shares held by its directors and senior management to maintain market order and comply with relevant laws and regulations [1][2] - This system applies to all shares held by directors and senior management, including those held in others' accounts and credit accounts [1][2] Shareholding Change Management and Disclosure - Directors and senior management must notify the board secretary in writing before buying or selling company shares, and the board secretary must verify compliance with laws and regulations [2][3] - There are specific circumstances under which directors and senior management cannot transfer their shares, including within one year of the company's stock listing and within six months after leaving the company [2][3] - The maximum amount of shares that can be transferred by directors and senior management in a year is limited to 25% of their total holdings, with exceptions for certain circumstances [3][4] Reporting and Disclosure Requirements - Directors and senior management must report their share transfer plans to the stock exchange 15 trading days before the first sale, including details such as the number of shares and the reason for the transfer [4][5] - Any changes in shareholding must be disclosed within two trading days, including the number of shares before and after the change, the date, and the reason for the change [6][7] Trading Restrictions - Directors and senior management are prohibited from trading company shares during specific periods, such as 15 days before the annual or semi-annual report announcements [7][8] - Violations of trading regulations may result in the company taking measures to recover any profits made from illegal trading activities [8][9] Additional Provisions - The company board is responsible for interpreting the management system and can revise it based on changes in laws or company circumstances [10]